Nofisat Ismaila

American Society of Clinical Oncology

Papers

1

Total Citations

38

H-Index

1

About

Dr. Nofisat Ismaila is a leading voice in evidence-based oncology, whose work bridges clinical research and practice guidelines to improve outcomes for patients with head and neck cancers. Her primary research areas include oropharyngeal squamous cell carcinoma, transoral robotic surgery (TORS), and the development of multidisciplinary treatment frameworks. Dr. Ismaila’s most notable contribution is her authorship of the landmark ASCO guideline on TORS in the multidisciplinary care of patients with oropharyngeal cancer, a 2025 publication that has already garnered 38 citations. This work synthesizes rigorous literature reviews to provide actionable recommendations, shaping how surgical and oncologic teams collaborate to optimize patient care. Her impact is further amplified through her role in ASCO’s guideline methodology, ensuring that clinical recommendations are both evidence-based and clinically relevant. Dr. Ismaila’s dedication to translating complex data into clear, practice-changing guidance makes her an invaluable resource for clinicians and researchers seeking to integrate cutting-edge surgical techniques into comprehensive cancer care. Her contributions continue to influence treatment paradigms and improve survival outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
38
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline
38 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: American Society of Clinical Oncology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago